…of all clinical trials conducted in 2022 showed that Covid-19 came second. First-line AZ treatment for adults with biliary tract cancer approved The MHRA has approved Imfinzi in combination with…
…analysis of all clinical trials conducted in 2022 showed that Covid-19 came second. Three of the top five most-studied disease areas fell within oncology, with prostate cancer the third most-studied…
…week, particularly in cancer research, where there has been good news in pancreatic, urothelial and uveal cancers. The top stories: Accelerated development for Covid-19 monoclonal antibody A monoclonal antibody to…
A monoclonal antibody to prevent Covid-19 in vulnerable patients, AZD3152, has entered clinical trials less than 12 months after discovery. AstraZeneca has initiated the SUPERNOVA Phase I/III trial of AZD5156…
…the UK unilaterally waived batch testing requirements for products coming from the EU for two years, including for Covid-19 vaccines. The Association of the British Pharmaceutical Industry (ABPI) has welcomed…
…– Winter 2021/22 of DDW. They are called “Genomics boosts understanding of Covid-19 severity and susceptibility” and “Rare variant contribution to human disease”. The Covid-19 Host Genetics Initiative carried out…
…in Covid-19 news, researchers have emphatically proven that prednisolone should not be prescribed for olfactory disorders. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google…
…disorders. The NHS in England has fast tracked another cancer drug, and, in Covid-19 news, researchers have emphatically proven that prednisolone should not be prescribed for olfactory disorders. The top…
…for people to understand the ultimate aim was not to rush a new Covid-19 vaccine to market. “This is about the role this technology could play in safeguarding against future…
It has been proven that prednisolone does not improve sense of smell after Covid-19 and that for most patients this gradually improves over time regardless of treatment. The study authors…
…during the Covid-19 pandemic. To make the same great strides tackling AMR, we must arm researchers with the tools to better manage data and accelerate the discovery of new antimicrobials.”…
…biomedical and health research in recovering from the Covid-19 pandemic and its importance in addressing further threats to our health and economic security. It also calls for “internationally competitive R&D…
…more than 50%. “Our teams have worked on a number of global clinical trials in close collaboration with the wider organisation and, of course, on several Covid-19 trials. However, what…
…malaria prevention. Meanwhile, the quest to understand Covid-19 continues, as study findings reveal how the virus affects the brain and the effectiveness of vaccines in those with compromised immunity. You…
